InvestWiser

Vaxxa AB

VAXXANasdaq StockholmTechnologyMarket value 11 m SEK
0.26SEK +2.8%
last day · Price as of 17 November 2026

The answer first

Does Vaxxa beat the market?

No, Vaxxa has not beaten the market over the last year.

Vaxxa−57.1%Stockholm (OMXSGI)+18.4%
  • Expectations in the price

    Low expectations

    For the share to return about 9% a year from today's price, it is enough that the cash Vaxxa keeps shrinks about 20% a year for 10 years.

Max for seven days

Follow Vaxxa with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 17 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Vaxxa

From today, at a price of 0.26 SEK. Write why you follow Vaxxa, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Vaxxa

Your first answer is free, no account needed.

Do you own Vaxxa, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Vaxxa and a few more. Free, no card.

Past year against the exchange and Super Stock
Vaxxa−54.5%Stockholm (OMXSGI)+18.4%Super Stock+45.9%
14 November 202517 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Vaxxa has fallen 57.1% over the past year, including dividends.
  • The largest fall over the past three years was 95.3%. The price is 99.9% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

Quality–
The company · Fundamentals: the accounts
  • Debt to equityBorrowings divided by equity0.00
  • Asset turnoverSales divided by everything the company owns3.62
  • Return on equityProfit divided by equity−38.2%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value–
The price · Valuation: the multiples
  • P/BPrice divided by equity0.9
  • P/SPrice divided by sales0.1
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flow3.8

The ranking is built on P/E, P/B and P/S.

Trend–
The share price · Technical: the price trend
  • 3 months−36.3%
  • 6 months−48.0%
  • 9 months−61.6%
  • 12 months−57.1%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−34.6%
3 years, per year
−34.3%
5 years, per year
−51.7%
Year to date
−58.6%
Largest fall, 3 years
−95.3%
From a peak to the bottom
From the peak now
−99.9%
How far the price is from the peak
Volatility, 1 year
101.5%
How much the price swings over a year
Beta, 1 year
0.62
How much the price moves when the market moves

Return with dividends reinvested.

About Vaxxa

Vaxxa AB is a company in technology, listed on Nasdaq Stockholm. The share trades in SEK. It has around 9 employees.

Vaxxa AB (publ) operates an auction platform, vaxxa.se, which provides private individuals and companies to sell and buy used objects in vehicles, machinery, and construction industry. The company was formerly known as Augeo Group AB and changed its name to Vaxxa AB (publ) in July 2023. Vaxxa AB (publ) was incorporated in 2015 and is based in Stockholm, Sweden.

See the full analysis of Vaxxa.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other technology stocks on Nasdaq Stockholm

Explore the stock market